These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9648879)

  • 1. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies.
    Lyras L; Perry RH; Perry EK; Ince PG; Jenner A; Jenner P; Halliwell B
    J Neurochem; 1998 Jul; 71(1):302-12. PubMed ID: 9648879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease.
    Lyras L; Cairns NJ; Jenner A; Jenner P; Halliwell B
    J Neurochem; 1997 May; 68(5):2061-9. PubMed ID: 9109533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased nuclear DNA oxidation in the brain in Alzheimer's disease.
    Gabbita SP; Lovell MA; Markesbery WR
    J Neurochem; 1998 Nov; 71(5):2034-40. PubMed ID: 9798928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA oxidation in Alzheimer's disease.
    Markesbery WR; Lovell MA
    Antioxid Redox Signal; 2006; 8(11-12):2039-45. PubMed ID: 17034348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
    Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
    Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative damage in pregnant diabetic rats and their embryos.
    Viana M; Aruoma OI; Herrera E; Bonet B
    Free Radic Biol Med; 2000 Dec; 29(11):1115-21. PubMed ID: 11121718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facts about the artifacts in the measurement of oxidative DNA base damage by gas chromatography-mass spectrometry.
    Dizdaroglu M
    Free Radic Res; 1998 Dec; 29(6):551-63. PubMed ID: 10098459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of oxidative DNA base damage by gas chromatography-mass spectrometry. Effect of derivatization conditions on artifactual formation of certain base oxidation products.
    England TG; Jenner A; Aruoma OI; Halliwell B
    Free Radic Res; 1998 Oct; 29(4):321-30. PubMed ID: 9860047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of oxidized and chlorinated bases in DNA treated with reactive oxygen species: implications for assessment of oxidative damage in vivo.
    Whiteman M; Hong HS; Jenner A; Halliwell B
    Biochem Biophys Res Commun; 2002 Aug; 296(4):883-9. PubMed ID: 12200130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies.
    Owen AD; Schapira AH; Jenner P; Marsden CD
    J Neural Transm Suppl; 1997; 51():167-73. PubMed ID: 9470137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative DNA base damage in lymphocytes of HIV-infected drug users.
    Jaruga P; Jaruga B; Olczak A; Halota W; Olinski R
    Free Radic Res; 1999 Sep; 31(3):197-200. PubMed ID: 10499776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of oxidative DNA damage by gas chromatography-mass spectrometry: ethanethiol prevents artifactual generation of oxidized DNA bases.
    Jenner A; England TG; Aruoma OI; Halliwell B
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):365-9. PubMed ID: 9531471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced intraneuronal lipofuscin content in dementia with Lewy bodies compared with Alzheimer's disease and controls.
    Drach LM; Bohl J; Wach S; Schlote W; Goebel HH
    Dement Geriatr Cogn Disord; 1998; 9(1):1-5. PubMed ID: 9469257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease.
    Ishii K; Imamura T; Sasaki M; Yamaji S; Sakamoto S; Kitagaki H; Hashimoto M; Hirono N; Shimomura T; Mori E
    Neurology; 1998 Jul; 51(1):125-30. PubMed ID: 9674790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease.
    Lovell MA; Markesbery WR
    Nucleic Acids Res; 2007; 35(22):7497-504. PubMed ID: 17947327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.